News Daily News CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR Todd Neale December 30, 2020
News Conference News AHA 2020 Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS Michael O'Riordan November 14, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
Presentation TCT 2020 TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI Presenter: Byeong-Keuk Kim October 14, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Conference News TCT 2020 No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH L.A. McKeown October 14, 2020
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Daily News Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis Yael L. Maxwell June 30, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020